These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 16508159)
1. Effects of gatifloxacin on serum glucose concentration in normal and diabetic rats. Ishiwata Y; Sanada Y; Yasuhara M Biol Pharm Bull; 2006 Mar; 29(3):527-31. PubMed ID: 16508159 [TBL] [Abstract][Full Text] [Related]
2. Gatifloxacin-induced histamine release and hyperglycemia in rats. Ishiwata Y; Yasuhara M Eur J Pharmacol; 2010 Oct; 645(1-3):192-7. PubMed ID: 20674567 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological aspect of dysglycemia in naive and diabetic rats induced by the fluoroquinolone antibacterial gatifloxacin. Nagai M; Nagata S; Yamagishi N; Satoh H; Furuhama K J Vet Med Sci; 2010 May; 72(5):567-73. PubMed ID: 20068268 [TBL] [Abstract][Full Text] [Related]
4. Effect of levofloxacin on serum glucose concentration in rats. Ishiwata Y; Itoga Y; Yasuhara M Eur J Pharmacol; 2006 Dec; 551(1-3):168-74. PubMed ID: 17026994 [TBL] [Abstract][Full Text] [Related]
5. Gatifloxacin induces augmented insulin release and intracellular insulin depletion of pancreatic islet cells. Tomita T; Onishi M; Sato E; Kimura Y; Kihira K Biol Pharm Bull; 2007 Apr; 30(4):644-7. PubMed ID: 17409495 [TBL] [Abstract][Full Text] [Related]
6. Combined contributions of over-secreted glucagon-like peptide 1 and suppressed insulin secretion to hyperglycemia induced by gatifloxacin in rats. Yu Y; Wang X; Liu C; Yao D; Hu M; Li J; Hu N; Liu L; Liu X Toxicol Appl Pharmacol; 2013 Feb; 266(3):375-84. PubMed ID: 23200776 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of simultaneous and sequential monitoring of glucose level and electrocardiogram in monkeys treated with gatifloxacin under conscious and nonrestricted conditions. Yoshimatsu Y; Ishizaka T; Chiba K; Mori K Exp Anim; 2018 May; 67(2):281-290. PubMed ID: 29311442 [TBL] [Abstract][Full Text] [Related]
8. Effects of moxifloxacin on serum glucose concentrations in rats. Ishiwata Y; Takahashi Y; Nagata M; Yasuhara M Biol Pharm Bull; 2013; 36(4):686-90. PubMed ID: 23358329 [TBL] [Abstract][Full Text] [Related]
9. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus. Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170 [TBL] [Abstract][Full Text] [Related]
10. Mechanism Underlying Induction of Hyperglycemia in Rats by Single Administration of Olanzapine. Nagata M; Nakajima M; Ishiwata Y; Takahashi Y; Takahashi H; Negishi K; Yasuhara M Biol Pharm Bull; 2016; 39(5):754-61. PubMed ID: 27150145 [TBL] [Abstract][Full Text] [Related]
11. Effects of gatifloxaine content in gatifloxacine-loaded PLGA and β-tricalcium phosphate composites on efficacy in treating osteomyelitis. Kimishima K; Matsuno T; Makiishi J; Tamazawa G; Sogo Y; Ito A; Satoh T Odontology; 2016 Jan; 104(1):105-13. PubMed ID: 25533357 [TBL] [Abstract][Full Text] [Related]
12. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats. Qinna NA; Badwan AA Drug Des Devel Ther; 2015; 9():2515-25. PubMed ID: 26005328 [TBL] [Abstract][Full Text] [Related]
13. Effects of glucose and some oral hypoglycemic agents upon the plasma glucose and immuno-reactive insulin (IRI) in normal and streptozotocin induced diabetic rat. Kaul CL; Talwalker PK; Grewal RS Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):139-44. PubMed ID: 708137 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of clinical dosage of gatifloxacin for respiratory tract infections in elderly patients based on pharmacokinetics/pharmacodynamics (PK/PD). Niki Y; Yoshida K; Miyashita N; Oka M; Hara H; Kishimoto M; Okimoto N; Kawanishi M; Uno M; Kamao T; Yoneyama H; Nakamura J; Kimura M; Watanabe M; Tanimukai T; Moriya O; Matsushima T J Infect Chemother; 2008 Aug; 14(4):296-304. PubMed ID: 18709533 [TBL] [Abstract][Full Text] [Related]
15. Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies. Gavin JR; Kubin R; Choudhri S; Kubitza D; Himmel H; Gross R; Meyer JM Drug Saf; 2004; 27(9):671-86. PubMed ID: 15230648 [TBL] [Abstract][Full Text] [Related]
17. Antidiabetogenic efficiency of menthol, improves glucose homeostasis and attenuates pancreatic β-cell apoptosis in streptozotocin-nicotinamide induced experimental rats through ameliorating glucose metabolic enzymes. Muruganathan U; Srinivasan S; Vinothkumar V Biomed Pharmacother; 2017 Aug; 92():229-239. PubMed ID: 28549291 [TBL] [Abstract][Full Text] [Related]
18. Serum prolactin concentrations determine whether they improve or impair β-cell function and insulin sensitivity in diabetic rats. Park S; Kim DS; Daily JW; Kim SH Diabetes Metab Res Rev; 2011 Sep; 27(6):564-74. PubMed ID: 21557442 [TBL] [Abstract][Full Text] [Related]
19. The 6-fluoro-8-methoxy quinolone gatifloxacin down-regulates interleukin-8 production in prostate cell line PC-3. Takeyama K; Mitsuzawa H; Nishitani C; Shimizu T; Sano H; Kunishima Y; Takahashi S; Hotta H; Matsukawa M; Shibata K; Tsukamoto T; Kuroki Y Antimicrob Agents Chemother; 2007 Jan; 51(1):162-8. PubMed ID: 17043111 [TBL] [Abstract][Full Text] [Related]
20. Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates β-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes. Akarte AS; Srinivasan BP; Gandhi S J Diabetes Complications; 2012; 26(4):266-74. PubMed ID: 22626875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]